Publicaciones en colaboración con investigadoras/es de Hospital de Cruces (79)

2024

  1. ATM germ line pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies

    Blood, Vol. 144, Núm. 11, pp. 1193-1205

  2. Cancer is not a risk factor for severe COVID-19 in children, except in patients with recent allogeneic hematopoietic stem cell transplantation or comorbidities

    Pediatric Blood and Cancer, Vol. 71, Núm. 8

  3. CircRNAome of Childhood Acute Lymphoblastic Leukemia: Deciphering Subtype-Specific Expression Profiles and Involvement in TCF3::PBX1 ALL

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

  4. The ECHO recommendations for dealing with vinblastine shortage affecting standard treatment of systemic Langerhans cell histiocytosis

    Pediatric Blood and Cancer

2023

  1. Analysis of germline variants in pediatric patients diagnosed with desmoid tumors and nuchal-type fibromas

    Translational Pediatrics, Vol. 12, Núm. 9, pp. 1715-1724

  2. How do hospitalised children die? The context of death and end-of-life decision-making

    Journal of Paediatrics and Child Health, Vol. 59, Núm. 4, pp. 625-630

  3. Identification of germline cancer predisposition variants in pediatric sarcoma patients from somatic tumor testing

    Scientific Reports, Vol. 13, Núm. 1

  4. Key Genes of the Immune System and Predisposition to Acquired Hemophilia A: Evidence from a Spanish Cohort of 49 Patients Using Next-Generation Sequencing

    International Journal of Molecular Sciences, Vol. 24, Núm. 22

2022

  1. A Three-Protein Panel to Support the Diagnosis of Sepsis in Children

    Journal of Clinical Medicine, Vol. 11, Núm. 6

  2. Clinical management of the acute complications of sickle cell anemia: 11 years of experience in a tertiary hospital

    Anales de Pediatria, Vol. 97, Núm. 1, pp. 4-11

  3. Complicaciones óseas en pacientes con leucemia linfoblástica aguda y linfomas

    Boletín de la Sociedad Vasco-Navarra de pediatría = Euskal Herriko Pediatria Elkartearen aldizkaria, Núm. 123, pp. 37-40

  4. Current status of precision medicine in pediatric oncology in Spain: a consensus report by the Spanish Society of Paediatric Haematology and Oncology (SEHOP)

    Clinical and Translational Oncology, Vol. 24, Núm. 5, pp. 809-815

  5. Identification and Functional Analysis of a Novel CTNNB1 Mutation in Pediatric Medulloblastoma

    Cancers, Vol. 14, Núm. 2

  6. Splicing-Disrupting Mutations in Inherited Predisposition to Solid Pediatric Cancer

    Cancers, Vol. 14, Núm. 23

  7. Tapering of the thrombopoietin receptor agonist in paediatric patients with chronic immune thrombocytopenia: Is it possible?

    British Journal of Clinical Pharmacology, Vol. 88, Núm. 9, pp. 4220-4223

2021

  1. Etoposide for Cytokine Storm Because of Coronavirus Disease 2019

    Chest

  2. Experiencia del cribado neonatal de enfermedad de células falciformes en un hospital terciario

    Boletín de la Sociedad Vasco-Navarra de pediatría = Euskal Herriko Pediatria Elkartearen aldizkaria, Núm. 122, pp. 11-17

  3. Importance of timely treatment initiation in infantile-onset pompe disease, a single-centre experience

    Children, Vol. 8, Núm. 11

  4. Use of antiangiogenic therapies in pediatric solid tumors

    Cancers, Vol. 13, Núm. 2, pp. 1-23

2020

  1. Role of rs10406069 in miR-5196 in hyperdiploid childhood acute lymphoblastic leukemia

    Epigenomics, Vol. 12, Núm. 22, pp. 1949-1955